, clinical or/and radiological suspicion (Figure 3 and 4) . Clinical features, radiological and laboratory investigations and outcomes were reviewed by medical records. Univariate analysis was performed to identify factors related to death. We performed descriptive statistics on percentage (%), median, mean and range. A p value of <0.05 was considered significant.
Results
The PJP incidence rate in the group studied was estimated at 0,056. The mean/median age were 37/40 (range: 14-76) years. A male predominance (65%) was observed. The median duration of length of ICU stay was 4 days (range: 1-57). 57% had evolved to Aids for more than a year. 92% cases occurred with cell count CD4 ⁺ less than 100 cells/µL with a mean of 52. Only one patient had more than 200 CD4+. 90% did not receive highly active antiretroviral therapy. 75% presented weight loss >10% during the last 6 months, Karnofsky scale <50 or hypoalbuminemia < 2,6 g/L. 70% presented diffuse bilateral interstitial infiltrates on chest X ray and 10% pneumothorax. 87% presented severe acute hypoxemic respiratory failure on admission, 40% required mechanical ventilation (MV). APACHE II (Acute Physiology and Chronic Health Evaluation II) score ≥13 points in 76% of the patients. The initial treatment was trimethoprim-sulfamethoxazole (and corticosteroids) which should be suspended due to adverse events in 25% (15% granulocytopenia, 5% exanthema and 5% hyperkalemia), it was replaced by intravenous pentamidine. Overall mortality was 43%. CD4+ <100 cells/µL (p=0,03) (table 1) 
